Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:288 (31 January), doi:10.1136/bmj.328.7434.288-c
| The first 150 words of the full text of this article appear below. |
EDITORMorris et al discussed the use of low dose colchicine in gout.1 The treatment dose of colchicine, which has remained at 1 mg initially, followed by 500 µg every 2-3 hours for many years, should be reviewed. However, they are incorrect to say that the current BNF (British National Formulary) recommends a regimen for colchicine that is unchanged since the 1966 edition.
In September 1999 the BNF reduced the total dose of a course of colchicine from 10 mg to 6 mg.2 Before 1981 the BNF did not even state the higher limit of 10 mg.
The decision to reduce the total dose of colchichine to 6 mg was taken because of expert advice given to the BNF.3 The formulary committee reported that it found little evidence to support the use of the total dose of 10 mg and that a total dose of 6
Anthony R Cox, pharmacist
City Hospital, Birmingham B18 7QH coxar@hotmail.com